Kudos to Dan Zandberg, MD of
@UPMC for one of the Most Significant
@ALLIANCE_org Manuscripts 2024-2025! "Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma" in JCO
#AllianceFall25 #NCI #NCTN